Technische Daten
Kontrolle:Skin carcinoma
Zelluläre Lokalisation:Nuclear
Vorbehandlung:ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Immunogen:Synthetic peptide of human C-Myc
Ig Unterklasse:IgG
Status:In Vitro Diagnostic Use (IVD)
Change(s) made:Complete revision
Synonyme:AU016757, Avian myelocytomatosis viral oncogene homolog, bHLHe39, c Myc, Cellular myelocytomatosis oncogene, MGC105490, MRTL, Myc protein, Myc proto oncogene protein, Myc-related translation/localization regulatory factor, Myc2, myca, Myelocytomatosis oncogene a, Myelocytomatosis oncogene, Niard, Nird, Oncogene Myc, Protooncogene homologous to myelocytomatosis virus, RNCMYC, Transcription factor p64, Transcriptional regulator Myc-A, v myc avian myelocytomatosis viral oncogene homolog, v myc myelocytomatosis viral oncogene homolog (avian), V-Myc avian myelocytomatosis viral oncogene homolog, v-myc myelocytomatosis viral oncogene homolog (avian), zc-myc.
Verfügbar in folgenden Ländern:worldwide

c-Myc is a transcription factor required for cell cycle progression and cell proliferation. Burkitt lymphoma is almost uniformly associated with chromosomal translocations involving c-Myc gene. Additionally, oncogene c-Myc is involved in tumorigenesis of multiple cancers, including breast, liver, pancreas and prostate cancer.


[1] Jacobson C and LaCasce A (2014): How I treat Burkitt lymphoma in adults. Blood. 124(19): 2913-2920.
[2] Mundim FG, Pasini FS, Brentani MM et al. (2015): MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 3(3): 506-514.
[3] Xu M, Liu Q, Jia Y et al. (2016): BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma. Oncol Lett. 12(4): 2648-2656.
[4] He C, Jiang H, Geng S et al. (2012): Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer. Int J Clin Exp Pathol. 5(4): 339-346.
[5] Yang G, Goltsov AA, Ren C et al. (2012): Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Mol Cancer Res. 10(2): 218-229.